You are here:
Case Study: Organotypic human in vitro models of embryonic morphogenetic fusion
Abbott, B., D. Belair, Cynthiaj Wolf, K. Das, C. Wood, W. Winnik, A. Fisher, R. Grindstaff, A. Swank, H. Ren, AND W. Padgett. Case Study: Organotypic human in vitro models of embryonic morphogenetic fusion. BoSC Meeting, RTP, NC, November 16 - 17, 2016.
The purpose of the poster is to indicate progress on the CSS 17.02 Virtual Tissue Models Morphogenesis Task 1 products for the Board of Scientific Counselors meeting on Nov 16-17.
Morphogenetic fusion of tissues is a common event in embryonic development and disruption of fusion is associated with birth defects of the eye, heart, neural tube, phallus, palate, and other organ systems. Embryonic tissue fusion requires precise regulation of cell-cell and cell-matrix interactions that drive proliferation, differentiation, and morphogenesis. Chemical low-dose exposures can disrupt morphogenesis across space and time by interfering with key embryonic fusion events. The Morphogenetic Fusion Task uses computer and in vitro models to elucidate consequences of developmental exposures. The Morphogenetic Fusion Task integrates multiple approaches to model responses to chemicals that leaad to birth defects, including integrative mining on ToxCast DB, ToxRefDB, and chemical structures, advanced computer agent-based models, and human cell-based cultures that model disruption of cellular and molecular behaviors including mechanisms predicted from integrative data mining and agent-based models.